Most Recent
The judge overseeing a class action over the $85 million sale of a Sydney development has expressed a more favourable view of the plaintiffs’ claims than a judge who denied them an interim injunction.
A judge has approved a settlement in a class action against Monsanto under which group members will get nothing, after he rejected claims that the company's Roundup weed killer is carcinogenic.
As it fends off a suit by AstraZeneca seeking to block the sale of a cheaper version of Brilinta, generics maker Pharmacor claims a patent for the heart attack drug should not have been extended.
A review of allegations against WiseTech founder Richard White has cleared the billionaire of misconduct, finding no misuse of company funds and characterising his behaviour in the workplace as “creative abrasion" not bullying.
Clyde & Co has been hit with a lawsuit by insurers who say they were wrongly advised to indemnify a builder in a legal dispute.
A former NAB employee has taken the bank to court alleging her employment offer was rescinded after her boss discovered she was pregnant.
Construction PRO
Logistics giant Qube has partially prevailed in setting aside amounts Martinus Rail claimed it was owed under a contract for work at an intermodal freight terminal in Moorebank, NSW.
An NRL player who is suing the Bulldogs for mental harm after he was allegedly forced to wrestle 30 other players as punishment must hand over correspondence between his solicitor and doctor.
AI tech company Paige can't patent a tool to provide quality control for analysis of pathology images, with IP Australia finding the invention is merely an “administrative scheme” to automate the role of human pathologists.
On appeal of a $6 million judgment for misleading statements, Dominique Grubisa and her wealth education company DG Institute have argued her advice was based on faulty knowledge, not ill intentions.